You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 20, 2024

Claims for Patent: 5,958,724


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 5,958,724
Title: Process for producing heme proteins
Abstract:The present invention relates to methods for producing heterologous heme proteins extracellularly comprising transforming a filamentous fungus with a vector comprising a DNA sequence encoding the heterologous heme protein and a DNA sequence encoding a preregion permitting secretion of the expressed heme protein, and culturing the transformed filamentous fungus in a suitable culture medium to produce the heme protein.
Inventor(s): Dalb.o slashed.ge; Henrik (Virum, DK), Jensen; Ejner Bech (Virum, DK), Welinder; Karen Gjesing (Virum, DK)
Assignee: Novo Nordisk A/S (Bagsvaerd, DK)
Application Number:08/858,933
Patent Claims:1. A process for the extracellular production of a heterologous heme protein in a strain of Aspergillus sp., the process comprising:

(a) transforming a suitable strain of an Aspergillus sp. with a recombinant DNA vector which comprises a DNA sequence encoding a heterologous heme protein, and a DNA sequence encoding a preregion permitting secretion of the expressed heme protein, and

(b) culturing the transformed strain of Aspergillus sp. in a suitable culture medium under conditions conducive to the production of the heme protein.

2. A process according to claim 1, wherein the heme protein produced by the Aspergillus sp. in step (b) is subsequently recovered from the culture.

3. A process according to claim 1, wherein the Aspergillus sp. is Aspergillus oryzae.

4. A process according to claim 1, wherein the preregion is derived from a gene encoding an Aspergillus sp amylase.

5. A process according to claim 1, wherein the preregion is derived from the gene encoding A. oryzae TAKA amylase, A. niger neutral .alpha.-amylase, A. niger acid-stable .alpha.-amylase, A. niger glucoamylase, or the peroxidase produced by Coprinus cinereus or macrorhizus.

6. A process according to any of claims 1, wherein the heme protein is an oxidoreductase.

7. A process according to claim 6, wherein the oxidoreductase is a peroxidase or a haloperoxidase.

8. A process according to claim 7 wherein the DNA sequence encoding the peroxidase is derived from a Coprinus sp., in particular Coprinus macrorhizus or cinereus.

9. A process according to claim 1, wherein the culture medium comprises hemin or a heme-containing material.

10. A process according to claim 9, wherein said hemin is present in the medium at a concentration of between 1 and 1000 .mu.g/ml.

11. A process according to claim 9, wherein said heme-containing material is selected from the group consisting of hemoglobin and red blood cells.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.